These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10659402)

  • 1. MK 869. L 754030, MK 0869.
    Drugs R D; 1999 Oct; 2(4):249-50. PubMed ID: 10659402
    [No Abstract]   [Full Text] [Related]  

  • 2. CJ 11974.
    Drugs R D; 1999 Oct; 2(4):241-2. PubMed ID: 10659398
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurokinin antagonism and chemotherapy-induced emesis.
    Shanahan F; O'Sullivan GC
    Am J Gastroenterol; 1999 Nov; 94(11):3368-9. PubMed ID: 10566748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of chemotherapy-induced nausea and vomiting].
    Herrstedt J
    Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemesis.
    Ettinger DS; Bierman PJ; Bradbury B; Comish CC; Ellis G; Ignoffo RJ; Kirkegaard S; Kloth DD; Kris MG; Lim D; Markiewicz MA; McNulty R; Nabati L; Todaro B; Urba S; Yowell S;
    J Natl Compr Canc Netw; 2007 Jan; 5(1):12-33. PubMed ID: 17239323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurokinin antagonists as antiemetics].
    Heinzl S
    Med Monatsschr Pharm; 2003 Oct; 26(10):336-7. PubMed ID: 14587153
    [No Abstract]   [Full Text] [Related]  

  • 7. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E
    J Pain Palliat Care Pharmacother; 2005; 19(3):31-9. PubMed ID: 16219609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
    Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
    Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palonosetron. RS 25259, RS 25259 197.
    Drugs R D; 1999 Oct; 2(4):251-2. PubMed ID: 10659403
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprepitant: a novel antiemetic for chemotherapy-induced nausea and vomiting.
    Massaro AM; Lenz KL
    Ann Pharmacother; 2005 Jan; 39(1):77-85. PubMed ID: 15562136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of nausea and vomiting. Aprepitant, the first therapeutic acting NK-1 receptor antagonist].
    Nieber K; Schoppmeyer K
    Pharm Unserer Zeit; 2007; 36(5):373-80. PubMed ID: 17722144
    [No Abstract]   [Full Text] [Related]  

  • 14. Rolapitant for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2015; 15(10):1127-33. PubMed ID: 26366937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting.
    Diemunsch P; Joshi GP; Brichant JF
    Br J Anaesth; 2009 Jul; 103(1):7-13. PubMed ID: 19454547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does neurokinin-1-receptor antagonist aprepitant diminish the efficacy of cyclophosphamide-based chemotherapy?
    Paiva CE; Paiva BS; Michelin OC
    Sao Paulo Med J; 2009 Nov; 127(6):385-6. PubMed ID: 20512296
    [No Abstract]   [Full Text] [Related]  

  • 17. BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
    Reilly RT
    IDrugs; 2004 Jan; 7(1):64-9. PubMed ID: 14730469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM; Dimitrijevic J; Djordjevic F
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic agents.
    Wilkes G
    Oncology (Williston Park); 2007 Jul; 21(8 Suppl):48. PubMed ID: 17844897
    [No Abstract]   [Full Text] [Related]  

  • 20. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.